KolmarBNH Co., Ltd.

KolmarBNH Co., Ltd.

KKRX:200130
7,560.00
KRW
-130.00
(-1.69%)
-52.41EPS
227.77BMarket Cap
Nov 18Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
91,090.38
8,151.11
8,669.38
11,423.96
13,080.56
14,854.6
20,540.28
20,075.96
19,489.21
19,818.54
21,177.85
20,287.27
19,018.65
Basic EPS, GAAP
10,989.31
39
1,006
1,549
1,637
1,844
2,724
2,365
1,371
674
621
-800
-55.14
Free Cash Flow per Basic Share
5,589.91
403.79
297.18
1,435.77
355.08
1,363.98
1,114.19
802.56
-1,499.87
-1,220.16
-290.66
550.12
797.9
Dividend per Share
221.7
- -
62.52
129.97
170.6
199.96
252.49
322.2
389.12
315.42
309.01
382.96
75.52
Book Value per Share
21,123.71
3,370.33
4,302.01
5,713.72
6,928.2
8,544.7
10,999.84
13,050.51
13,594.67
13,692.74
13,867.67
12,502.97
13,466.89
Tangible Book Value per Share
20,965.41
3,358.2
4,293.42
5,203.07
6,355.99
7,963.42
10,391.07
12,298.87
12,858.71
12,978.01
13,064.89
12,115.47
13,055.91
Basic Weighted Avg Shares
2
29
30
30
30
30
30
30
30
29
29
28
28
Sales/Revenue/Turnover
173,932
236,187
256,010
337,569
386,366
438,906
606,892
593,081
575,903
579,552
615,642
574,885
538,176
Operating Margin (%)
13.11
14.58
14.14
14.45
15.15
16.88
17.99
15.45
10.61
5.22
4
4.4
5.85
Depreciation Expense
1,323
1,879
2,148
3,436
4,142
5,208
8,486
11,522
14,517
16,510
19,058
19,605
18,075
Net Income, GAAP
20,984
1,130
29,708
45,772
48,353
54,484
80,484
69,866
40,513
19,710
18,053
-22,670
-1,560
Effective Tax Rate (%)
20.8
89.45
22.75
19.56
23.21
24.01
26.98
25.59
27.69
27.9
26.42
- -
143.02
Profit Margin (%)
12.06
0.48
11.6
13.56
12.51
12.41
13.26
11.78
7.03
3.4
2.93
-3.94
-0.29
Working Capital
17,765
50,554
65,585
66,875
70,254
91,283
129,684
144,973
86,142
7,031
-12,607
30,815
123,857
LT Debt
1,452
- -
- -
55
- -
13,107
22,869
23,622
58,125
76,426
55,776
96,310
103,393
Total Equity
60,611
100,938
128,742
177,924
206,529
254,551
327,593
386,640
402,687
396,302
395,266
355,476
382,679
Return on Invested Capital (%)
- -
4.07
22.45
23.01
21.17
21.87
23.45
15.91
8.59
3.73
2.94
- -
-2.56
Return on Capital (%)
- -
1.29
25.07
27.04
23.34
22.03
25.15
17.62
8.49
4.48
4.16
- -
-0.73
Return on Common Equity (%)
- -
1.42
26.21
30.94
25.89
23.84
27.88
19.67
10.29
4.93
4.54
-6.04
-0.4

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
119,173
38,338
8,462
LT Borrowings
93,480
109,333
101,000
LT Finance Leases
2,830
2,685
2,393
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
28
28
28
Market Capitalization
362,175
323,128
227,774

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
224,614
226,549
205,370
Cash, Cash Equivalents & STI
110,509
121,742
90,123
Accounts Receivable, Net
28,550
24,478
31,773
Inventories
76,834
67,765
74,801
Total Current Liabilities
193,799
98,823
81,513
Payables & Accruals
- -
- -
- -
ST Debt
119,173
38,338
8,462
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.4%
2.05%
-10.07%
Free Cash Flow
-14.61%
-139.04%
-284.49%
Net Income, GAAP
230.84%
-68.11%
-225.58%
Sales/Revenue/Turnover
10.16%
-0.99%
-6.62%
Total Cash Common Dividend
- -
9.36%
20.81%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
160,225
165,920
147,445
142,052
615,642
2025
136,729
164,102
151,828
122,226
574,885
2026
136,890
127,233
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
233
183
130
73.88
621
2025
50
237
218
-1,306.77
-800
2026
788.56
245
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.51
- -
309.01
2025
- -
- -
75.5
- -
382.96
2026
- -
- -
- -
- -
- -

Company Description

Full Time Employees
468
Sector
Health technology
Industry
Pharmaceuticals: other
Address
Sejong-si South Korea
IPO Date
Jul 23, 2014
Business
Kolmar BNH Co Ltd is a leading original development manufacturing (ODM) company specializing in health functional foods and packaging products. The company manufactures a diverse portfolio including health supplements, dietary supplements, and related functional products; packaging solutions such as PTP/multi-PTP, powder stick/pouch, three-side cloth, four-side, and liquid stick packaging; and offers comprehensive ODM consulting services. Kolmar BNH operates globally, supplying products to over 26 countries including the United States, China, Australia, and South Korea. Founded through the merger of SunbioTech and Korea Food & Farm, Kolmar BNH is headquartered in South Korea and upholds international standards with certifications from the US FDA, Health Canada, MUI Halal, and Australian TGA for quality assurance in manufacturing. Recently, Kolmar BNH has advanced its sustainability initiatives, publishing its 2025 ESG report which highlights continued efforts towards eco-friendly technologies, corporate responsibility, and long-term value creation. The company has achieved Korea’s health functional food industry’s first-ever consecutive Green Technology Certifications and operates a smart farm for sustainable raw material supply using hydroponic methods. Safety and governance are strengthened with ISO certifications for occupational health (ISO 45001), anti-corruption (ISO 37001), and compliance management (ISO 37301), along with zero serious workplace accidents for three consecutive years. Recent product developments include eco-friendly health supplements like HemoHIM, which has gained certification for added health function and National Adverse Event Reporting System (NAI) classification from the US FDA. Kolmar BNH continues to expand its R&D, dedicating a significant portion of its workforce and sales to research, reinforcing its position as a sustainable global health food ODM provider.